These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 33994708)
1. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. Choudhary NS; Dhampalwar S; Saraf N; Soin AS J Clin Exp Hepatol; 2021; 11(6):713-719. PubMed ID: 33994708 [TBL] [Abstract][Full Text] [Related]
2. Predictors of in-hospital Outcomes in Patients With Cirrhosis and Coronavirus Disease-2019. Elhence A; Vaishnav M; Biswas S; Anand A; Gunjan D; Kedia S; Mahapatra SJ; Nayak B; Sheikh S; Soni KD; Trikha A; Goel A; Shalimar J Clin Exp Hepatol; 2022; 12(3):876-886. PubMed ID: 34728983 [TBL] [Abstract][Full Text] [Related]
3. Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis. Frager SZ; Szymanski J; Schwartz JM; Massoumi HS; Kinkhabwala M; Wolkoff AW Hepatol Commun; 2021 Mar; 5(3):424-433. PubMed ID: 33681677 [TBL] [Abstract][Full Text] [Related]
4. Incidence, characteristics, and outcome of COVID-19 in patients on liver transplant program: a retrospective study in the north of Iran. Samidoust P; Esmaeili Delshad MS; Navid Talemi R; Mojtahedi K; Samidoust A; Jahangiri S; Ashoobi MT New Microbes New Infect; 2021 Nov; 44():100935. PubMed ID: 34493955 [TBL] [Abstract][Full Text] [Related]
5. Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know? Sharma P; Kumar A; Anikhindi S; Bansal N; Singla V; Shivam K; Arora A J Clin Exp Hepatol; 2021; 11(4):484-493. PubMed ID: 33398223 [TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. Boettler T; Marjot T; Newsome PN; Mondelli MU; Maticic M; Cordero E; Jalan R; Moreau R; Cornberg M; Berg T JHEP Rep; 2020 Oct; 2(5):100169. PubMed ID: 32835190 [TBL] [Abstract][Full Text] [Related]
8. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. Boettler T; Newsome PN; Mondelli MU; Maticic M; Cordero E; Cornberg M; Berg T JHEP Rep; 2020 Jun; 2(3):100113. PubMed ID: 32289115 [TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study. Satapathy SK; Roth NC; Kvasnovsky C; Hirsch JS; Trindade AJ; Molmenti E; Barish M; Hirschwerk D; Da BL; Bernstein D; Hepatol Int; 2021 Jun; 15(3):766-779. PubMed ID: 33826042 [TBL] [Abstract][Full Text] [Related]
10. Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis? Türker F; Oral A; Şahin T; Türker BÇ; Koçak E; Ataoğlu HE; Ahbab S J Int Med Res; 2021 Nov; 49(11):3000605211056841. PubMed ID: 34763561 [TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis. Rivas G; Hummer-Bair B; Bezinover D; Kadry Z; Stine J BMJ Open Gastroenterol; 2021 Jul; 8(1):. PubMed ID: 34341018 [TBL] [Abstract][Full Text] [Related]
13. Implications of anaemia and response to anaemia treatment on outcomes in patients with cirrhosis. Rashidi-Alavijeh J; Nuruzade N; Frey A; Huessler EM; Hörster A; Zeller AC; Schütte A; Schmidt H; Willuweit K; Lange CM JHEP Rep; 2023 Apr; 5(4):100688. PubMed ID: 36926273 [TBL] [Abstract][Full Text] [Related]
14. The Outcome in Cirrhosis after Hospital Discharge is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis. Vaishnav M; Elhence A; Biswas S; Pathak P; Anand A; Sheikh S; Singh V; Maitra S; Goel A; Shalimar J Clin Exp Hepatol; 2022; 12(3):830-840. PubMed ID: 34840484 [TBL] [Abstract][Full Text] [Related]
15. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma. Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270 [TBL] [Abstract][Full Text] [Related]
16. Coronavirus Disease-2019 and Implications on the Liver. Campbell PT; Fix OK Clin Liver Dis; 2023 Feb; 27(1):27-45. PubMed ID: 36400465 [TBL] [Abstract][Full Text] [Related]
17. Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update. Sripongpun P; Pinpathomrat N; Bruminhent J; Kaewdech A Front Med (Lausanne); 2022; 9():924454. PubMed ID: 35814781 [TBL] [Abstract][Full Text] [Related]
18. Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease. Canbay A; Kachru N; Haas JS; Sowa JP; Meise D; Ozbay AB Aliment Pharmacol Ther; 2020 Oct; 52(7):1185-1194. PubMed ID: 33016540 [TBL] [Abstract][Full Text] [Related]
19. Liver Transplant Society of India Guidelines for Liver Transplant During COVID-19 times. Gupta S; Sudhindran S; Saraf N; Vijai A; Swaminathan S; Panackel C; Mehta NN; Varghese J; Singh S; Reddy MS; M Sivaramakrishnan V; Bhangui P; Mohanka R; Asthana S; Rohatgi S J Clin Exp Hepatol; 2022; 12(1):180-185. PubMed ID: 34429571 [TBL] [Abstract][Full Text] [Related]